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ABSTRACT 
Congenital ectopia lentis (EL) is an ocular condition, which typically causes a high 
grade of refractive errors, mainly myopia and astigmatism. These might be difficult to 
compensate for, especially in children, who might develop ametropic amblyopia. 
Surgery on ectopic lenses has previously been controversial, due to the risk of sight-
threatening complications.  
 In paper I we studied retrospectively visual outcomes and complications 
in children, who were operated for congenital EL, and who had en scleral-fixated 
capsular tension ring (CTR) and an intra-ocular lens (IOL) implanted at the primary 
surgery. Thirty-seven eyes of 22 children were included. Visual acuity (VA) improved 
in all eyes, and only few had persistent amblyopia at the end of the follow-up. A great 
majority of the eyes had postoperative visual axis opacification (VAO), which was 
expected, since the posterior capsule was left intact at the primary surgery. Two eyes 
required secondary suturing for IOL decentration. No eye had any serious 
complications such as retinal detachment, glaucoma or endophthalmitis.  
 Congenital ectopia lentis is often an indicator of a systemic connective 
tissue disorder, and Marfan syndrome (MFS) is diagnosed in 70% of the cases. This 
genetic disorder affects basically all organ systems in the body, EL and dilatation of the 
ascending aorta being the cardinal signs. MFS is associated with markedly decreased 
life expectancy due to the cardiovascular complications. Therefore, an early and 
accurate diagnosis is of importance.  
In paper II we measured the accommodative power, lens thickness, 
anterior chamber depth (ACD), and pupil size in these eyes, using an optical coherence 
tomography (OCT). Thirty-one eyes of 31 cases of MFS were included, and these were 
compared to non-affected controls. We found that the lens was significantly thicker in 
MFS at all stages. The pupil size was significantly smaller in MFS at baseline, 
decreased less in accommodation and dilated more during dilatation. No significant 
difference was seen in the accommodative power or ACD. No difference was seen in 
any parameter between the MFS eyes with, and without EL. We conclude, that even 
though the lens and the pupil seem to be affected in MFS, these eyes seem to have the 
same ability to accommodate as normal subjects. The observed changes seem to be 
associated to MFS independently of EL. 
In paper III we studied the corneal curvature, thickness and endothelial 
cell density (ECD) in 39 MFS eyes and compared those to non-affected controls. We 
found significantly lower keratometric (K) values and corneal thickness in MFS, but no 
difference in the ECD. No significant difference was found in these parameters 
between MFS eyes with and without EL. We also reported on generally increased 
corneal astigmatism in MFS, especially in eyes with EL.  
In paper IV we described the ocular characteristics in 102 eyes of 56 
cases of MFS. We found increased axial length, but mostly only moderate myopia, 
which seemed to be compensated by the flat cornea. The majority of the eyes had EL, 
or were pseudophakic due to EL. Other associated diagnosis included amblyopia, 
glaucoma, retinal detachment and strabismus.  
In conclusion, we found that surgery for EL in children, including CTR 
and IOL gives good visual development and no serious complications. Also, most of 
the ocular changes in MFS seem to be connected to MFS itself, rather than EL.  
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1 ECTOPIA LENTIS – INTRODUCTION 
 
1.1 DEFINITION 
Ectopia lentis is defined as a displacement of the crystalline lens of the eye from its 
normal location. The lens is normally positioned posterior of the pupillary aperture, 
centered in the middle of the pupil with its thickest part along with the optical axis 
(Figure 1). If the lens is partly displaced, it is referred to as subluxated, and if totally 
displaced, it is referred to as luxated. Lens ectopia can be divided into congenital and 
non-congenital type. In this thesis only congenital lens ectopia will be discussed.  
 
 
 
 
Figure 1. The anatomy of a human eye.  
 
 
1.2 THE OPTICAL FUNCTION OF THE LENS 
The crystalline lens plays an important role in the optical system of the eye. It gathers 
the rays of light entering the eye in a single spot, fovea centralis, on the retina, in the 
posterior pole of the eye. The total refractive power of a relaxed eye is approximately 
60 diopters (D). The light rays entering the eye are first converged in the cornea, which 
is a convex, light-permeable structure on the anterior part of the eye, and has a 
refractive power of approximately 40 D. The light rays are then further converged as 
they pass through the lens, with a power of approximately 20 D. Also aqueous and 
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vitreous humors contribute to convergence, but account for a minor part of the total 
refractive power.  
The crystalline lens embodies a unique ability to adapt its light-refractive power, 
depending on the distance to the object, which the eye is focused on. This focusing 
ability, accommodation, is possible due to the elastic structure of the lens, and the thin 
threads (zonulae) that are attached radially from its outermost edge (equator) to the 
ciliary muscle around it. When looking at distance, the ciliary muscle is relaxed, the 
zonulae are stretched, and the lens is flat. Changing the focus on a closer target, 
however, makes the ciliary muscle to contract, allowing the lens to get thicker. This 
will increase the refractive power of the lens. The degree of accommodation, the 
accommodative amplitude, is about 20 D at the age of 10 years, and is gradually 
decreased with age. By the age of about 60 years, the accommodative amplitude is 
practically non-existent. This loss of accommodative ability is called presbyopia.  
The exact mechanism of accommodation and causes of presbyopia have been 
discussed. According to the ruling theory on accommodation, described by Helmholtz 
(Von Helmholtz 1855), the contraction of the ciliary muscle allows all the zonulae to 
relax, thereby allowing the elastic lens capsule to contract, causing a decrease in the 
equatorial diameter, a decrease in the radii of curvature of the anterior and posterior 
lens surfaces, and an increase in axial lens thickness (Schachar et al. 1996). According 
to this hypothesis, presbyopia is caused by loss of elasticity of the lens capsule and/or 
sclerosis of the lens nucleus, with decreased ability to change its shape.  
Lately, electronmicroscopic studies on the structures around the lens, zonules, 
and ciliary body have revealed that the anterior and posterior lens zonules originate 
from the surface of pars plicata, while the equatorial zonules originate from anterior 
valleys between the ciliary processes (Stachs et al. 2006). It has also been shown that 
the equator of the lens moves peripherally towards the sclera during accommodation 
(Schachar et al. 1996). It has therefore been proposed by Schachar that accommodation 
is a product of increased tension in the equatorial zonules, which causes flattening and 
increased diameter of the lens equator; and decreased tension in the anterior and 
posterior zonules, causing steepening of the anterior and posterior lens surface 
(Schachar et al. 1996; Schachar 2004; Schachar 2006). Since the lens is of ectodermal 
origin, and continues to grow throughout life (ca. 0.02 mm/year), while the sclera does 
not change significantly after childhood, it is postulated that the effective force that the 
ciliary body can apply to the lens equator decreases with age. According to this theory, 
presbyopia results from normal lens growth, rather than structural changes in the lens 
(Schachar 2006). 
 
 
1.3 EPIDEMIOLOGY  
In a large Danish retrospective study on epidemiology and characterisation of 
conditions associated to ectopia lentis, 396 cases of ectopia lentis were studied and 
classified (Fuchs &  Rosenberg 1998). In this study the reported prevalence rate of 
ectopia lentis at birth was 0.83/10,000 live born, and 6.4 /100,000 in general 
population.  
In their study, the nosological classification was possible in only 70% of these 
cases, but the authors found that the great majority of the cases (68%) also had Marfan 
syndrome (MFS) (Figure 2). Other diagnoses included: 
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- Ectopia lentis et pupillae   21%  
- Simple dominant ectopia lentis  8.0% 
- Homocysteinuria   1.1% 
- Sulfite oxidase deficiency   0.7% 
- Weill-Marchesani syndrome   0.7%  
 
It seems apparent that ectopia lentis is often a part of a systemic condition, and in a 
majority of the cases Marfan syndrome. Therefore, the work-up of ectopia lentis 
should always include a general medical examination. Marfan syndrome will be 
described in detail in chapter 2.  
 
 
Figure 2. A superiotemporal subluxation of the lens in Marfan syndrome. 
 
 
Ectopia lentis et pupillae is a rare condition, in which remnants of the pupillary 
membrane are present, often bilaterally. The pupil is oval or slit-shaped and 
dislocated in opposite directions than the lens. Other features include iris 
transillumination in the iris periphery, high myopia and poor vision. It is autosomal 
recessive condition, which lacks the systemic signs of MFS (Cruysberg &  Pinckers 
1995).  
’Simple dominant ectopia lentis’, or familial ectopia lentis, is a condition with 
some skeletal features of MFS and a mutation in the same gene as in MFS, the FBN1 
gene. They lack, however, the risk of aortic risk found in MFS. Since aortic dilatation 
and aneurysm may arise later in life, even patients with familial ectopia lentis should 
be followed up with cardiovascular imaging throughout the life.  
Homocysteinuria is a condition, which in addition to ectopia lentis, is 
associated to mental retardation and thrombosis. The diagnosis is based on an 
analysis on urine amino acids in the absence of pyridoxine supplementation. The lens 
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is typically dislocated downward, due to total loss of zonular support (Pyeritz &  
McKusick 1979). 
Sulfite oxidase deficiency is a rare, but fatal disease, causing neurological 
disorders, mental retardation, degradation of the brain, and death. In some cases 
ectopia lentis have been seen (Lee 2011).  
Weill-Marchesani syndrome is associated with microsherophakia (small, thick 
and round lens), and shallow anterior chamber. The affected cases are short, have 
bradydachtyly (short and stubby hands and feet) and joint stiffness. The ocular 
features include high myopia (due to dislocated lens), cataract and glaucoma. Both 
autosomal dominant and recessive inheritance occur (Faivre et al. 2003). In the 
dominant cases, FBN1 mutations are found.  
  
 
1.4 PATHOPHYSIOLOGY 
In 1986, fibrillin 1 was identified as a major component of the extracellular matrix 
microfibril (Sakai et al. 1986), which is present in skin, lung, kidney, vasculature 
cartilage, tendon, muscle, cornea and ciliary zonules (Kielty et al. 2005). Thus, it is 
found in practically all tissues with clinical manifestations of MFS. Fibrillins are large 
glycoproteins that are polymerized in to bead-like microfibrils, including epidermal 
growth factor-like domains, as well as TGF-β binding protein-like domains (Ramirez &  
Sakai 2010). These microfibrils can occur independently in the extracellular matrix, or 
associate with elastin in elastic fibers.      
The ciliary zonules anchor the crystalline lens radially from the equator of the 
lens to the surrounding ciliary body. These zonular fibers are composed of elastic core, 
covered with microfibrils containing fibrillin 1. Fibrillin 1 is mainly secreted by the 
cells of non-pigmented epithelium of the ciliary body (Hanssen et al. 2001). Although 
the secretion of new fibrillin decreases with age, the amount of fibrillin present in 
zonules is the same, probably due to remodelling of the microfibrils. This gives the 
zonular microfibrils a shorter and increasingly disorganized appearance, which may 
reflect an increased cross-linking of the microfibrils during ageing (Hanssen et al. 
1998).  
Besides in the zonules, fibrillin has been seen in various structures of the human 
eye (Wheatley et al. 1995). In the anterior segment, fibrillin has been seen the lens 
capsule; connective tissues of the iris, ciliary body, ciliary processes and conjunctiva; 
the basement membrane of the corneal epithelium (mainly in the periphery) and 
endothelium of Schlemm’s canal. In the posterior segment fibrillin has been localized 
in the lamina cribrosa, sclera, choroid, around the retinal vessels and retinal pigment 
epithelium.  
The exact mechanism causing zonular stretching in ectopia lentis is still 
unknown, but it seems that pathologic fibrillin 1 found in systemic conditions 
associated with ectopia lentis could be more susceptible to proteolysis (Reinhardt et al. 
2000). When the fibrillin polymers are proteolyzed into monomers, the amount of free 
fibrillin increases in the extracellular matrix. The free fibrillin 1 fragments are then 
believed to cause upregulation of extracellular matrix proteins and antiproteases, 
including matrix metalloproteinases (MMPs), which in turn leads to degradation of 
microfibrils (Booms et al. 2005). On the other hand, it is not known whether there 
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could be structural changes in the zonules in the direction of ectopia, causing traction 
on the lens and secondary stretching in the zonules at the opposite side of the lens.  
On the lens capsule, three distinct zones containing fibrillin may be seen in the 
equatorial and periequatorial regions of a normal lens capsule. These regions are 
platforms for zonular attachment on the surface on the lens. Fibrillins in these areas 
show significant quantitative and qualitative defects in MFS, and show abnormal and 
disrupted appearance when imaged (Mir et al. 1998; Traboulsi et al. 2000). The zonules 
in MFS are thin, stretched and irregular in diameter. Substantial differences in the 
quality of fibrillin 1 have also been shown in conjunctiva of MFS patients with ectopia 
lentis, compared to unaffected controls (Ganesh et al. 2006). These changes lay ground 
for a causative relationship between abnormalities in the quality and quantity of 
fibrillin-containing microfibrils in the lens capsule and lens ectopia in MFS.  
 
 
1.5 CONSEQUENCES AND COMPLICATIONS 
1.5.1 Myopia and astigmatism 
Myopia and astigmatism are the most common consequences of lens ectopia. Dagi and 
Walton (Dagi &  Walton 2006) have outlined the two types of mechanisms leading to 
progressive myopia in ectopia lentis: firstly, the anterior displacement of the lens and 
the iris, moving the focal point of the eye forward, and secondly, the relaxation of the 
zonulae, giving rise to more spherical shape of the lens, and thereby increasing its 
refractive power. Progressive ectopia lentis also causes irregular astigmatism, which 
may result in blurred vision and monocular diplopia.  
 
1.5.2 Glaucoma 
Glaucoma is seen more frequently in MFS than in general population (Izquierdo et al. 
1992). Primary open-angle glaucoma (POAG) is seen most often, but it may arise via 
several mechanisms (Nemet et al. 2006):  
1) POAG. Without any obvious anatomical or mechanical reason, but sometimes 
displacement of Schlemm’s canal or unusual prominence of the canal and 
aqueous veins are seen (Allen et al. 1967).  
2) Secondary angle-closure glaucoma. In ectopia lentis, the lens may move 
forward, displacing the iris forward, thereby narrowing the angle. This may be 
enhanced by vitreous dislocation into the anterior segment (Ritch et al. 2003; 
Barkana et al. 2006) (Figure 3). 
3) Pupillary block glaucoma, in which the lens is subluxated anteriorly, blocking 
the aqueous humor circulation. The lens may be pressed against the pupillary 
borders, incarcerated in the pupillary aperture, or dislocated into the anterior 
chamber. Treatment of increased intra-ocular pressure (IOP) with pilocarpine at 
this state is contraindicated. The situation should instead be managed with pupil 
dilating topical medication, supine positioning of the patient in order to replace 
the lens, peripheral iridotomy, and lens extraction.  
4) Pigment dispersion glaucoma, caused by contact of the mobile crystalline lens 
with the iris (Doyle et al. 2005). 
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Figure 3. Ectopia lentis is associated with an increased risk of glaucoma and retinal detachment 
through several possible mechanisms. 
 
1.5.3 Retina  
Ectopia lentis and aphakia are associated with an increased risk of retinal detachment. 
In addition, MFS increases this risk, ranging from 5-25% in different case series 
(Nemet et al. 2006). This is mainly due to increased axial length (Maumenee 1981) and 
is often seen bilaterally in MFS (Dotrelova 1998). Also, the ectopic lens may cause 
vitreous traction. Fibrillin is found in the walls of retinal vessels, which could 
contribute to formation of retinal breaks and detachment in MFS (Wheatley et al. 
1995). Further, the retinal ruptures or early detachments may be easily missed in MFS 
due to a small, poorly dilating pupil and lens abnormalities (Remulla &  Tolentino 
2001).  
 
 
1.6 SURGICAL TREATMENT OF ECTOPIA LENTIS 
1.6.1 Introduction 
The modern techniques of lens surgery have developed due to the need for effective 
and safe methods for treatment of cataract. Although cataract at early age is a common 
feature in ectopia lentis, many cases of ectopia lentis are operated mainly on refractive 
indications. This is true especially in children, who may now gain from the 
development of these techniques, and be operated at early age.  
 The golden standard of cataract surgery today is phacoemulsification with 
posterior-chamber intraocular lens (PCIOL). However, in case of poor zonular support, 
there is an increased risk of capsular tears, vitreous loss, retained lens material and 
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intraocular lens (IOL) decentration/dislocation. Before the development of the current 
techniques, these cases required extracapsular cataract extraction (ECCE), intracapsular 
cataract extraction (ICCE), or pars plana lensectomy.  
 The alternatives for surgical correction of aphakia, when the posterior 
capsule is extracted, are the anterior-chamber IOL (ACIOL) and scleral-fixated PCIOL. 
The ACIOL is found in mainly two types: one fixated in the angle, and the other one is 
iris claw lens, which is today, in some cases, fixated retropupillary. However, the risk 
of vitreous loss and retinal detachment are decreased, if the lens capsule is left intact. 
Therefore, an IOL implanted in the bag seems like a safer alternative in cases of lens 
ectopia.  
 
1.6.2 Endocapsular devices 
The introduction of capsular support devices – capsular tension rings (CTRs), modified 
CTRs (M-CTRs), capsular tension segments (CTSs), and iris/capsule support hooks – 
have improved the safety of lens surgery in cases of poor zonular support, and they 
have come as welcomed instruments for lens surgeons, who face these challenging 
situations (Figure 4). They all contribute to preservation and stabilisation of the 
capsular bag so that PCIOL may be safely implanted and the PCIOL remains stable 
post-operatively.  
 
 
          
              
Figure 4. An illustration of some endocapsular devices. From the top left, clockwise: capsular 
tension ring (CTR), modified CTR with one eyelet, capsular tension segment, and modified 
CTR with two eyelets. (MORCHER® GmbH, Germany) 
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1.6.2.1 Capsular tension ring  
A CTR is an open, compressible, polymethylmethacrylate (PMMA) ring with a 
rounded eyelet at each end of the ring. Since its diameter is slightly greater than the 
capsular bag, it exerts a centrifugal force at the equator, expands the capsular bag and 
redistributes tension from the weakened zonules to stronger, intact zonules (Blecher &  
Kirk 2008). The first CTR was introduced by Hara et al. in 1991 (Hara et al. 1991). 
This was a redesign of a previous endocapsular device introduced in Japan in the late 
1980s, which was designed for preventing migration of epithelial cells and posterior 
capsule opacification (Hasanee &  Ahmed 2006). The ‘equator ring’ created by Hara et 
al. had a closed-ring structure, which limited its use in capsular bags of varying sizes. 
Also in 1991, Nagamoto and Bissen-Miyajuma presented an open PMMA ring 
developed for capsular support (Nagamoto &  Bissen-Miyajima 1994). These rings 
were popularized and further developed by Legler and BM Witschel. 
 
1.6.2.2 Modified capsular tension ring 
Before the introduction of M-CTR, the cases of profound zonular support required 
more invasive and complicated surgery, since the standard CTR does not offer 
sufficient support in those cases. Sometimes, suturing of the CTS through the capsular 
bag, and fixating it to sclera was done (Lam et al. 2000). This procedure, however, 
increases the risk of capsular tears markedly, and disrupts the integrity of the capsular 
bag as a barrier between anterior and posterior segment, thus increasing the risk of peri- 
and postoperative complications. To address these issues, Cionni developed a M-CTR 
in 1998. It is a development of the traditional CTR, with the addition of one (model 1-L 
or 1-R) or two (model 2-L) fixation eyelets attached to the central ring, allowing 
fixation to sclera (Ahmed &  Crandall 2001; Kohnen et al. 2003). This device allows 
small-incision intraocular surgery and PCIOL implantation (Cionni et al. 2003; 
Moreno-Montanes et al. 2003) (Figure 5).  
  
Figure 5. A Cionni modified capsular tension ring (note the fixation eyelet superiorly), and a 3-piece 
IOL implanted in the bag. Visual axis opacification is seen in the posterior lens capsule. 
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1.6.2.3 Capsular tension segment 
Capsular tension segment was designed by Ahmed in 2002 (Hasanee &  Ahmed 2006). 
It is a partial PMMA ring segment, with 120 degrees width and a radius of 5 mm. Like 
M-CTR, CTS also possesses an anteriorly positioned fixation eyelet, which is used 
when fixating the segment to sclera.  
 
1.6.3 Indications 
The CTRs are useful and indicated in cases of mild zonular weakness (<4 clock hours), 
and possibly in cases of generalized zonular weakness in eyes with pseudoexfoliation 
(Gimbel et al. 1997; Jacob et al. 2003; Ahmed et al. 2005). In cases of moderate or 
advanced zonular dialysis, a CTR is considered to be insufficient. In these cases a M-
CTR or a CTS, which both provide fixation into sclera, is required. In case of anterior 
capsule tear, posterior capsule rent, incomplete rhexis, or in need for recentering a 
severely subluxated capsular bag, the use of CTR and M-CTR is contraindicated (Lang 
et al. 2001; Bopp &  Lucke 2003; Bhattacharjee et al. 2004).  
Due to the fact that CTS is smaller than a CTR or a M-CTR, it is easier to insert 
in the capsular bag, even before phacoemulsification. It is designed to glide in to the 
bag atraumatically, and thus transmits much less force on the weakened zonules than a 
CTR or a M-CTR does. Therefore, a CTS is a good option in cases of profound zonular 
dialysis. The advantage of the CTS is that it may be used even in cases of discontinuous 
capsulorrhexis, anterior capsule tear, or a posterior capsule rent. Several segments may 
be used, in cases of general zonular weakness.  
 
 
1.7 REFRACTIVE CORRECTION OF ECTOPIA LENTIS 
In mild cases of ectopia lentis, with a stable refraction, spectacles may be used for 
correction of ametropia. In children, however, this requires frequent follow-up of the 
visual acuity and possible changes in refraction, in order to avoid amblyopia. It has 
been shown that conservative treatment in ectopia lentis, despite of careful refraction, 
gives poor visual development, with ametropic functional amblyopia in 50% of the 
patients (Romano et al. 2002). 
Before the surgical management of ectopia lentis was developed to the standard 
that is seen today, aphakic contact lenses were recommended as the safest option for 
postoperative optical correction in pediatric lens ectopia (Neely &  Plager 2001). 
However, the management of contact lenses is challenging in children, and requires 
much attention from the parents, as well as close follow-up by ophthalmological 
specialists. It has been reported that contact lens wearing in MFS is associated with 
complications, such as neovascularisation, giant papillary conjunctivitis, and punctate 
staining, in 70% of the cases (Yeung &  Weissman 1997). Considering these facts, it 
seems reasonable to aim for surgical management of lens ectopia, including primary 
IOL implantation in the capsular bag, in pediatric cases of ectopia lentis.  
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2 MARFAN SYNDROME 
 
2.1 INTRODUCTION 
Marfan syndrome (MFS) is an autosomal dominant genetic condition, which affects 
both sexes equally, and has no ethnic predilection. The estimated incidence of MFS is 1 
per 5,000 (Pyeritz &  McKusick 1979), and about 20% of the cases are de novo 
mutations, without affected parents. MFS affects mainly the musculoskeletal, ocular 
and the cardiovascular organ systems. Also skin and integuments, lungs and dura are 
affected. The syndrome shows high genetic penetrance, but great inter- and 
intrafamilial variability of symptoms. Since the diagnosis is to a great extent based on 
clinical findings, the clinical variability makes the diagnostics of MFS challenging. 
Other major problems are that the typical manifestations become more apparent with 
age, high degree of de novo mutations, and clinical overlap with several other 
conditions.  
Professor A. Marfan was a French paediatrician, who lived in the late 19th 
century, was the first to describe skeletal abnormalities associated with 
‘arachnodactyly’ (spider-like fingers) in a 5-year old girl. Since then, other specific 
manifestations related to the skeletal changes have been found, mainly ocular (ectopia 
lentis) and cardiac changes with aortic root dilatation and rupture, as well as mitral 
valve prolaps.  
MFS may be diagnosed at all ages. The four most important reasons for referral 
to rule out MFS are family history of MFS, ectopia lentis and a variety of cardiac and 
skeletal manifestations associated with MFS (Hamod et al. 2003). The median age at 
diagnosis in children (0-18 years) is 6.5 years (Faivre et al. 2009). 
 
 
2.2 MOLECULAR GENETICS AND PATHOPHYSIOLOGY 
In 1991, mutations in fibrillin 1 (FBN1) gene, located in chromosome 15, were 
demonstrated as a cause for MFS (Dietz et al. 1991). This was a breakthrough in MFS 
diagnostics, since for the first time a specific location for genetic mutations could be 
associated to MFS. At the beginning, FBN1 mutations were demonstrated only in a 
minority of patients. It was subsequently shown that the frequency of finding FBN1 
was significantly higher in classic MFS (73%), but low in patients referred for analysis 
when having possible MFS (14%) (Stheneur et al. 2009). These results implicate the 
importance of using the clinical (Ghent) criteria as a tool for determining, which 
patients should be genetically analyzed for FBN1 mutations. Faivre et al., who studied 
a group of probands with a known FBN1 mutation, further analyzed this. They showed 
that when the clinical signs were used as a base for the diagnosis, also the number of 
patients with mutations in FBN1 gene increased (Faivre et al. 2008). When only 
clinical signs for MFS were used, 79% of the adults were diagnosed with MFS, but 
when the FBN1 mutation was included in the criteria, 90% fulfilled the international 
criteria. The corresponding figures for children were 56% and 85%, with increasing 
figures in the older groups, indicating the progressive nature of the clinical signs 
(Faivre et al. 2009).  
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By now, over 500 different mutations in FBN1 gene have been found and almost 
all of them are unique for the affected individual or family. This may partly explain the 
great variation in the clinical signs (Boileau et al. 2005). Even mutations in the 
transforming growth factor receptor 2 (TGFBR2) gene have been shown in some cases 
of MFS (Mizuguchi et al. 2004; Attias et al. 2009). The molecular biology methods 
have improved through the years, and they have become less expensive. Therefore, 
now more patients can be tested with these methods.  
Interestingly, it seems that there is a great inter- and intrafamilial variability in 
the spectrum of clinical signs, including risk for aortic complications, even within 
families with the same mutation. This could be explained by the two main hypotheses 
on how the FBN1 mutations disturb the normal function of fibrillin-1: 
- Dominant-negative effect, which is considered the most likely. According to 
this hypothesis, the mutate proteins perturb the function of the polymerized fibrillin-1. 
This is supported by the observation that the amount of fibrillin-1 in MFS is lower than 
expected if only one allele was functioning normally (Hollister et al. 1990).  
- Haploinsufficiency, according to which the abnormal protein is not produced, 
or is rapidly degradated. If this hypothesis is shown most likely, it could open for a new 
therapeutic method by boosting the fibrillin-1 production (Judge et al. 2004). 
In addition, some studies show that fibrillin-1 could, besides the structural effect 
on extracellular matrix, also affect the TGF-β signalling pathway (Neptune et al. 2003; 
Ng et al. 2004). This assumption seems logic, since fibrillin-1 contains TGF-β binding 
protein-like domains. TGF-β is a growth factor, which is bound in a latent form in the 
microfibrils. TGF-β has been shown present in excessive amounts in aneurysms of 
ascending aorta (Borges et al. 2010). When released from microfibrils by, for example, 
tissue injury, TGF-β is activated, stimulating the release of extracellular matrix proteins 
and antiproteases, including matrix metalloproteinases (MMPs), and it thereby activates 
tissue repair. The abundance and activity of MMPs have been shown to be associated to 
thoracic aortic aneurysms (TAA) in a number of studies (Barbour et al. 2007). This 
could be the pathomechanism behind aortic complications in MFS. The pathology of 
aortic aneurysm is caused by degradation of extracellular matrix in the aortic wall, 
which leads to decreased resistance against the blood pressure. These changes are 
similar in MFS and in other genetic, as well as non-genetic aetiologies, but occur at 
younger age in MFS, often around 40 years.  
 
 
2.3 CLINICAL SIGNS AND DIAGNOSTIC CRITERIA 
The view on MFS has evolved since it was first described. Great efforts have been 
made by groups of experts, in order to systematize the diagnostic criteria for MFS 
(Beighton et al. 1988; De Paepe et al. 1996; Loeys et al. 2010) The first consensus of 
the clinical criteria (Berlin criteria) (Beighton et al. 1988) was felt needed to facilitate 
communication about MFS between clinicians, patients and researchers.  
However, since the recognition of the mutation in FBN1 gene as a cause for MFS 
(Dietz et al. 1991), it became obvious that the Berlin nosology allowed falsely the 
diagnosis for MFS in individuals with family history of MFS, with unspecific 
connective tissue manifestations, but no genetic changes found in family members 
more affected by MFS. Therefore, the diagnostic criteria were up-dated, now including 
the mutations in FBN1 gene as part of the criteria (Ghent nosology) (De Paepe et al. 
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1996). The Ghent nosology served as a better tool for over-diagnosing of MFS and 
made it easier to differentiate MFS from other Marfan-like disorders, such as the 
myopia, mitral valve prolaps, borderline and non-progressive aortic root enlargement, 
skeletal findings and striae syndrome (MASS), and mitral valve prolaps syndrome 
(MVPS).  
The Ghent criteria used a combination of major and minor clinical criteria in 
basically all organ systems: skeletal, ocular, cardiovascular and pulmonary, as well as 
in dura, skin and integuement (De Paepe et al. 1996). The major criteria include ectopia 
lentis, aortic root dilatation/dissection, dural ectasia and at least 4 of the skeletal 
manifestations. In an index case, without family history of MFS, two major criteria and 
at least one minor criterion are needed for diagnosis. In case of typical FBN1 mutation, 
or a family member fulfilling the clinical criteria according to Ghent criteria, only one 
major and one minor criterion are required. The Ghent criteria served as a clinical tool 
for MFS diagnostics for many years. It has been shown that FBN1 mutations can be 
found in up to 91% of the cases of MFS fulfilling the Ghent criteria from 1996, which 
is an indication of high specificity in diagnosing MFS (Loeys et al. 2001; Loeys et al. 
2004). This specificity is, however, associated to adult populations, and does not take 
into account the natural age-dependent variation of some clinical findings. It is 
therefore not fully applicable in children (Faivre et al. 2009). The practical use of the 
criteria has also shown that the clinical criteria were not entirely validated with 
threshold values for the required signs, or necessitated expensive and specialized 
investigations.  
Therefore, the criteria were recently up-dated, with an emphasis on the two 
cardinal signs for MFS: aortic root aneurysm and ectopia lentis (Loeys et al. 2010). 
These new criteria are based on large patient cohorts, including clinical and molecular 
biological investigations on individuals with MFS and other fibrillinopathies (Loeys et 
al. 2001; Loeys et al. 2004; Faivre et al. 2007; Faivre et al. 2008). They now underline 
the importance of genetic testing of FBN1 and other relevant genes causing Marfan-
like phenotype. Further, some clinical signs with less specificity for MFS were 
removed or made less influential in the total diagnostic evaluation.  
 The main diagnostic criteria for MFS are, in the absence of family 
history: aortic root dilatation/dissection, in combination with EL, FBN 1 mutation or 
systemic score (≥7points). In the presence of family history, the presence of either EL, 
systemic score (≥7points), or aortic root dilatation/dissection, gives the diagnosis. For 
the systemic scoring, see Table 1. 
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2.4 OCULAR SIGNS 
2.4.1 Ocular diagnostic criteria 
The importance of ectopia lentis in diagnosing MFS has been undisputable ever since 
MFS was described. However, other ocular criteria in MFS have evolved together with 
the systemic criteria. In the Berlin nosology from 1988 (Beighton et al. 1988), ectopia 
lentis is described as a major feature, whereas flat cornea, elongated globe, retinal 
detachment and myopia are mentioned as minor features.  
In the Ghent criteria from 1996 (De Paepe et al. 1996), the clinical criteria 
are defined as major and minor and ectopia lentis is solely defined as a major ocular 
criterion for MFS. The minor ocular criteria include  
- abnormally flat cornea (as measured by keratometry) 
- increased axial length (as measured by ultrasound)  
- hypoplastic iris or hypoplastic ciliary muscle causing decreased 
miosis 
Since the clinical practice showed subsequently that these criteria were 
inadequately defined, and no threshold values were included in the criteria, they were 
difficult to use. Therefore, in the revised criteria from 2010, an extra emphasis is given 
for ectopia lentis in the diagnosis, in line with FBN1 mutation and aortic root 
enlargement/dissection.  
Besides ectopia lentis, high myopia is regarded as the most prominent ocular 
feature in MFS. It also shows early onset, high severity and rapid progression. 
Therefore, myopia >3D is now included in the systemic features in MFS. Corneal 
flattening and increased axial length are now considered having unclear specificity and 
not being routinely measured by ophthalmologists. These featured have therefore been 
removed from the ocular criteria.   
Table 1. Scoring of systemic features (Reproduced from Loeys et al: Revised Ghent criteria (Loeys et 
al. 2010)) 
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2.4.2 Lens 
The crystalline lens is typically subluxated upwards and temporally in MFS, but other 
directions may occur (Maumenee 1981). It is usually bilateral and symmetric, and seen 
in approximately 60% of the patients (Maumenee 1981; Sultan et al. 2002). In order to 
detect ectopia lentis, the eyes should be examined in the slit lamp after maximal 
dilatation. The main patient complaints in ectopia lentis are blurred vision and 
monocular diplopia caused by progressive lens subluxation and following astigmatism. 
Clinical findings include irido-phakodonesis and irregular astigmatism.  
 The reasons for the typical superotemporal subluxation, and the 
progressive subluxation with age, are not clear. An interesting theory has been 
proposed by Sachdev et al., who showed zonule-associated staining of MMPs in 
Marfan syndrome (Sachdev et al. 2002). Since defect fibrillin in MFS is believed to be 
more susceptible for proteolysis, MMPs are believed to be involved in the degradation 
of zonules. It has also been proposed that the UV-B light is mainly focused on the 
inferonasal portion of the cornea (Coroneo 1993; Narayanan et al. 1996), which could 
lead to increased UV-B light exposure also in the inferonasal zonules. In the skin, UV-
B has been shown to decrease fibrillin messenger RNA exposure (Werth et al. 1997). 
Considering these facts together, it seems plausible to assume that the inferonasal 
zonules, which are more exposed to UV-B light throughout life, would have decreased 
production of fibrillin, and the defect fibrillin would be the first to break.  
Due to ectopia lentis, cataract is seen at a younger age in MFS than in the 
general population. These cataracts are often posterior capsular opacities, or localized 
cortical opacities (Nemet et al. 2006). 
 
2.4.3 Refraction 
High myopia and astigmatism in MFS are caused by the same factors as described for 
ectopia lentis in general (1.5.1). Furthermore, in Marfan syndrome (MFS), the axial 
length is increased, contributing to additional myopia (Maumenee 1981; Setala et al. 
1988). The increased axial length could be explained by the abnormal microfibrils in 
the connective tissue of sclera and cornea (Wheatley et al. 1995). 
 
2.4.4 Cornea 
Abnormally flat cornea in MFS has been reported for many years (Maumenee 1981; 
Sultan et al. 2002; Heur et al. 2008). This feature was previously included as a minor 
criteria for MFS, but has now been removed (Beighton et al. 1988; De Paepe et al. 
1996). Interestingly, in these flat corneas, also high corneal astigmatism is common. 
Furthermore, both cornea and sclera are thinned in MFS (Heur et al. 2008). Unlike the 
traditional conception of the connection between MFS and keratoconus, no studies 
have shown a connection between these two conditions (Maumenee 1981; Heur et al. 
2008). 
 The reasons for corneal flattening are unknown. One hypothesis is that 
both corneal flattening and thinning are secondary to general enlargement of the globe 
in MFS. It could also be a primary corneal pathology, due to weakness in the corneal 
fibrillin. This hypothesis is supported by the fact that in immunohistochemical staining, 
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fibrillin is detected in the basement membrane region of the corneal epithelium, where 
a dense band of fibrillin is seen between the corneal epithelium and Bowman’s 
membrane (Wheatley et al. 1995). Fibrillin is seen mostly in the periphery of the 
cornea, and only scarcely in the central areas. Only minor fibrillin staining has been 
seen in the stroma, and it was localized to the spaces between the collagen lamellae. No 
fibrillin staining has been detected in the Descement’s membrane or the corneal 
endothelium. Since microfibrils might be a part of the anchoring system at the 
epithelial-mesenchymal basement membrane interface, the defects in the microfibrils 
could have a negative effect on the support of the corneal structure (Sultan et al. 2002).  
 Significant endothelial guttata-formation, cell pleomorphism, central 
black spots and in some cases abnormal endothelial cells have been seen in the cornea 
of MFS patients (Setala et al. 1988; Iordanidou et al. 2007). These features were most 
prominent in MFS eyes with ectopia lentis. No abnormal endothelial cell density has, 
however, been shown in MFS (Setala et al. 1988). 
 Megalocornea is a nonprogressive enlargement of the cornea to 13 mm or 
greater. The enlarged ciliary ring causes zonular stretching leading to phakodonesis, 
ectopia lentis, iridodonesis, iris stromal hypoplasia and transillumination defects 
(Nemet et al. 2006). In the context of MFS megalocornea is mainly associated to the 
neonatal form of MFS.  
 
2.4.5 Iris  
The iris sphincter and dilator muscles in MFS are typically poorly developed, which 
have been reported to cause eccentric and poorly dilated pupils, when pharmacological 
pupil dilating drops were used (Maumenee 1981). The crypts of the anterior iris surface 
are also frequently absent (Nemet et al. 2006).  
 
 
2.5 MEDICAL THERAPY 
The demonstration of the connection between the TGF-β signalling pathway and MFS 
has changed the view on MFS from a structural disease towards a functional one. This 
opens for new therapeutic strategies, which could have life-saving effects on MFS 
patients. While β-adrenergic receptor blockers are the standard medical treatment today 
for MFS patients in need for prevention and delaying aortic aneurysm, it now seems 
that losartan could be the drug of choice in the future. Losartan is mainly used for its 
hemodynamic effects in treatment of hypertonia, as it lowers the arterial pressure. It has 
been shown in mouse models of MFS that losartan prevented aortic-root enlargement 
and improved aortic wall structure by remodelling it (Habashi et al. 2006). Losartan has 
also shown effects outside the vascular system, in preventing emphysema and 
myopathy associated to MFS. Human studies have already been started (Lacro et al. 
2007; Radonic et al. 2010). If it is shown that losartan also works in regulating TGF-β 
activity in humans, this could be a welcomed improvement in the medical treatment of 
MFS. Also TGF-β antibodies have shown effect in mouse models, but their effect in 
humans remains unknown until further studied.  
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2.6 MORTALITY  
The mortality rates previously connected to MFS have been related mainly to the 
cardiovascular complications. The primary life-threatening complication in MFS is 
rupture of an aortic aneurysm. Besides being an important diagnostic factor, the aortic 
root diameter is one of the most important predicting factors for aortic dissection and 
rupture. Aortic root diameter > 50 mm is associated with a markedly increased risk of 
aortic rupture, and this diameter is considered an indication for surgical repair (Roman 
et al. 1993; Legget et al. 1996).  
In a study done in the early 1970’s, before the development of aortic 
surgery, the life expectancy of MFS patients was significantly shortened (Murdoch et 
al. 1972). In that study, the median (50%) cumulative probability of survival in MFS 
was 48 years, and the mean age at death was 32 years. The cardiovascular 
complications were the cause of death in > 90% of the cases, with aortic rupture 
accounting for 80% of the deaths.  
About 30 years later, the median (50%) cumulative probability of 
survival was reported considerably better, 72 years, and the mean age at death was 41 
years (Silverman et al. 1995). Also the life expectancy after aortic root surgery was 
reported higher, 61 years, than the total life expectancy in 1972 (Finkbohner et al. 
1995). The improvement of life expectancy could be explained by several factors: 
overall improvement in population life expectancy, developments in cardiovascular 
surgery, greater proportion of milder cases due to improved diagnostics, and medical 
treatment including β-blockers.  
 
 
2.7 NEONATAL MFS 
Neonatal MFS (nMFS) is a special form of MFS, which represents the most serious 
type of clinical manifestations of MFS. The mutations are typically clustered in a 
specific part of the FBN1 gene (exons 23-32), and basically all reported cases are de 
novo mutations (Putnam et al. 1996). Neonatal MFS carries the same clinical 
characteristics as classic MFS, with the addition of congenital flexion contractures, 
characteristic ‘aged-appearance’ of the face, megalocornea, ectopia lentis and crumpled 
ears (Morse et al. 1990; Booms et al. 1999). This form of MFS is associated with high 
mortality, often within the first months of life. This is due to serious cardiovascular 
complications, including ascending aorta dilatation, cardiac valve prolaps and 
following congestive heart failure at young age being the rule (Morse et al. 1990; 
Booms et al. 1999; Faivre et al. 2009). 
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3 GENERAL AIMS 
 
 
1. To study the visual outcomes in children who had had surgery for ectopia lentis 
including scleral fixated capsular tension ring (CTR) and implantation of an 
intraocular lens (IOL) in the primary surgery, and to study complications 
associated to this type of surgery (paper I). 
2. To compare the changes in the anterior segment during accommodation and 
cycloplegia in eyes predisposed to ectopia lentis (Marfan syndrome) and 
controls measured with optical coherence tomography (OCT) (paper II). 
3. To compare the corneal curvature, thickness and endothelial cell density in eyes 
predisposed to ectopia lentis (Marfan syndrome) and controls (paper III). 
4. To describe the ocular characteristics of eyes predisposed to ectopia lentis 
(Marfan syndrome) (paper IV). 
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4 MATERIAL AND METHODS 
 
4.1 PAPER I 
4.1.1 Patients and methods  
Patients in paper I were recruited by a search in the patient charts at St. Erik Eye 
Hospital, Stockholm, Sweden. Children, who had had surgery with a scleral fixated 
capsular tension ring (CTR) and primary intraocular lens (IOL) implantation for 
congenital ectopia lentis at St. Erik Eye Hospital, Stockholm, Sweden, between the 
years 2000 and 2005, were included.  
The patients were in many cases from outside Stockholm. The first 
postoperative follow-up was done by the surgeon on the first postoperative day. 
Thereafter the patients were followed up at their home clinics. The records of the visits 
until February 2006 were sent from the home clinics. The pre- and postoperatively best 
best-corrected visual acuity (BCVA) and complications were recorded.  
 
 
4.2 PAPER II 
4.2.1 Study design 
The participants with Marfan syndrome in paper II were recruited in cooperation with 
the departments of Cardiology, and Clinical Genetics, at the Karolinska University 
Hospital, Stockholm, Sweden. One hundred letters were sent to possible study 
candidates with MFS. Affected family members were also invited to participate. The 
study candidates were asked to contact the study group, if interested in participating in 
the study. Fifty-six candidates contacted us. The MFS group was compared to 
unaffected controls matched for age and refractive sphere. They were recruited among 
the hospital staff at St. Erik Eye Hospital, and their families.  
The parent or guardian of each child provided a signed informed consent form 
agreeing to participate in the study. Approval for this study was obtained from the local 
ethics committee.  
 
4.2.2 Inclusion/exclusion criteria 
The inclusion criteria were diagnosis of MFS based on the Ghent criteria, and age 12 
years or older to avoid participants without fully developed visual acuity (VA). A best-
corrected logarithm of the minimum angle of resolution (logMAR) visual acuity of 0.3 
or better was required, in order to ensure good focusing on the fixation point in the 
Visante OCT. The most myopic eye of each participant was included. Cases with 
suspected, but unverified diagnosis with MFS, or previous corneal/intraocular surgery 
were excluded. 
 
4.2.3 Method 
Prior to the examination with OCT, best spectacle-corrected visual acuity (BSCVA) 
and manifest refraction were measured. The eyes were also examined in slit-lamp, 
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before administrating cycloplegic eye drops, and in full dilatation/cycloplegia. The eyes 
were scanned with OCT at baseline, during accommodation and dilatation. The anterior 
chamber depth (ACD), pupil size and lens thickness were then measured in millimeters. 
The MFS eyes were compared to the controls. Subsequently, the MFS eyes with 
subluxation were compared to those without subluxation. 
 
4.2.4 Optical coherence tomography  
Optical coherence tomography (OCT), with 820-nm wavelength, is a well-known 
device for imaging the posterior segment of the eye (Huang et al. 1991). OCT for 
imaging of the anterior segment of the eye was introduced in 2001 (Radhakrishnan et 
al. 2001). It is a real-time imaging device using 1310-nm wavelength light, which does 
not include any contact with the surface of the eye (Figure 6). It suits well for imaging 
of the cornea, sclera, iris stroma and pigment epithelium, anterior chamber angle, and 
anterior surface of the lens, even through an opaque cornea. Since the light waves are 
blocked by pigment epithelium in the iris, the ciliary body and the equator of the lens 
are not visible when using OCT. However, as we show in paper II, even the posterior 
surface of the lens is visible with OCT.  
 
 
Figure 6. The anterior segment of a 19-year old male with Marfan syndrome, imaged with 
OCT.  
 
The fixation target in OCT can be focused with adding positive or negative lenses with 
a simple press of a button, to correct for any spherical ametropia the subject may have, 
and to produce imaging of the unaccommodated eye. The target may also be defocused 
adding negative lens power, in order to stimulate accommodation. As the eye 
accommodates, the pupil size is decreased, the anterior surface of the lens is pushed 
forward and the anterior chamber depth is decreased. These changes during 
accommodation may be observed and imaged in real time with OCT.  
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 Anterior segment OCT has shown to be a user-friendly instrument, with 
good repeatability and reproducibility (Muscat et al. 2002; Baikoff et al. 2004; Fine et 
al. 2007). It has been used in various diagnosis of the anterior segment, for instance in 
diagnostics of glaucoma (Ursea &  Silverman 2010) and in refractive surgery (Baikoff 
et al. 2005; Lai et al. 2006; Koivula &  Kugelberg 2007). In our study on 
accommodation, Visante OCT (Carl Zeiss, Jena, Germany) was used.  
 
 
4.2.5 Statistical Analysis 
Statistical analyses were performed using the Student’s t-test. A P value of less than 
0.05 was considered statistically significant.  
 
 
4.3 PAPER III 
4.3.1 Study design 
The same as for paper II. 
 
 
4.3.2 Inclusion/exclusion criteria 
The same as for paper II, but without limitation on VA.  
 
4.3.3 Method 
Prior to the corneal examination, best spectacle-corrected visual acuity (BSCVA) and 
manifest refraction were measured. The eyes were then scanned with Orbscan II 
Segment Analyzer. The corneal curvature and thickness at the thinnest point were 
measured in micrometers (µm). The endothelial cell layer was imaged using Topcon 
IMAGEnet-640, and the ECD in cells per mm² was assessed using a semi-automated 
method. The eyes were also examined in slit-lamp, before administrating cycloplegic 
eye drops, and in full dilatation/cycloplegia. The MFS eyes were compared to the 
controls. Subsequently, the MFS eyes with subluxation were compared to those without 
subluxation. 
 
4.3.4 Orbscan II Segment Analyzer  
The first Orbscan (Bausch & Lomb Inc., Rochester, NY, USA) corneal topography 
using slitscanning technique was introduced in 1995. This device was later enhanced to 
Orbscan II Segment Analyzer, which is a corneal topography system using a 
combination of slitscanning and placido technique (Swartz et al. 2007). It analyzes the 
anterior and posterior edge of the light slits, and creates a three-dimensional map of the 
cornea using the two-dimensional images. The maps present elevation and curvature of 
both anterior and posterior surfaces the cornea, as well as corneal thickness. Orbscan II 
has shown good accuracy of measurement (Cairns et al. 2002; Gonzalez Perez et al. 
2004), and is widely used in healthy populations (Wei et al. 2006), diagnostics of 
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corneal diseases (e.g. keratoconus) (Lim et al. 2007), and is today an essential part of 
planning for refractive surgery.  
 
4.3.5 Statistical Analysis 
Statistical analyses were performed using the Student’s t-test for most parameters. The 
Mann Whitney U test was applied for sphere since the data were not normally 
distributed. For cross tabulations, the chi-square test or the two-tailed Fisher’s exact test 
was used. A P value of less than 0.05 was considered statistically significant. Odds 
Ratio (OR) for some suggested diagnostic values in corneal changes and their 
association with MFS were also calculated.  
 
 
4.4 PAPER IV 
4.4.1 Study design 
The same as for paper II. However, since this was a descriptive study, no control group 
was used.  
 
4.4.2 Inclusion/exclusion criteria 
The same as for paper II. However, both eyes of each participant were included, and 
there was no limitation on VA. 
 
4.4.3 Method 
At first, the best spectacle-corrected visual acuity (BSCVA) and manifest refraction 
were measured. The eyes were then scanned with IOLMaster, and the axial bulb length 
was noted. The eyes were also examined in slit-lamp, before administrating cycloplegic 
eye drops, and in full dilatation/cycloplegia. Full ophthalmologic history, including 
previous ocular surgery, was obtained from the participants.  
 
4.4.4 Statistical Analysis 
Since study IV was an investigative observational analysis, no comparative analyses 
were performed. However, a descriptive statistical analysis was performed. 
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5 RESULTS AND DISCUSSION 
 
5.1 PAPER I 
5.1.1 Patient data 
In this retrospective study, 37 eyes of 22 children with a median age of 52 months 
(range, 17 to 131 months) at the time of primary surgery were included. The median 
follow-up time was 27 months (range, 1 to 59 months). Six patients were diagnosed 
with Marfan syndrome. Other ethiologies included familial lens dislocation (2 patients), 
spherophakia (2), and idiopathic lens dislocation (12).  
 
5.1.2 Visual outcomes 
The visual acuity was measured with several different charts, depending on the 
maturity of the patient and the local traditions in each clinic. BCVA could be measured 
preoperatively with a Lea Hyvärinen (LH) chart and letter charts in 22 eyes. The mean 
BCVA for those eyes was 0.26 decimal (range, 0.015 to 0.65), including one patient 
tested binocularly (one eye included) (Figure 7).  
All patients could be tested for BCVA with LH or letter chart postoperatively. 
The mean BCVA after (primary or secondary) surgery of 36 eyes was 0.59 (range 0.2 
to1.0), including one patient tested binocularly. All non-amblyopic eyes had a 
postoperative minimum BCVA of 0.4 (range, 0.4 to 1.0), and three patients with 
persistent amblyopia had a postoperative BCVA 0.2 to 0.4 at the end of the follow-up.  
 
Figure 7. Diagram showing decimal pre- and postoperative best-corrected visual 
acuity (BCVA) in 21 eyes. The dotted line indicates no change. All squares are 
above the line indicating improvement in BCVA in all eyes. 
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Despite the postoperative improvement of visual acuity in nearly all patients, many 
eyes in this study did not reach full visual acuity. This could be explained by many 
factors: most importantly, the age by the time of the primary surgery affects the 
postoperative visual acuity. Early surgery seems to be associated with better visual 
rehabilitation. Many patients in this series had been treated conservatively for many 
years, and had already developed amblyopia. Further, the youngest patients were still 
very young at the end of the follow-up, and the visual acuity could therefore be 
expected to improve. The follow-up was also in some cases relatively short, and did not 
show the fully developed post-operative visual acuity in those cases. Finally, some eyes 
had mild visual axis opacification (VAO), which was not treated during the follow-up 
time. After treatment for VAO, a better VA could be expected also in those eyes.  
 Conservative management of ectopia lentis has shown to give poor visual 
development (Romano et al. 2002). Aphakia, surgical or spontaneous, on the other 
hand, gives better visual development (Behki et al. 1990; Speedwell &  Russell-Eggitt 
1995; Shortt et al. 2004), but leaves the patient with a need of great refractive 
correction, either with spectacles or contact lenses. Considering the high grade of 
refractive correction needed in the spectacles, and that contact lens related 
complications are common, primary IOL implantation seems like a good alternative in 
management of ectopia lentis. This, however, requires good control of the capsular bag 
during the surgery. Some type of capsular tension device is therefore needed in these 
cases, preferably a scleral-fixated (Cionni) ring, which does not compromise the 
integrity of the posterior lens capsule (Ahmed &  Crandall 2001). In this paper we 
show that this intraocular device gives a good visual development in children with 
congenital EL. 
 
5.1.3 Complications 
Thirty-one of the total 37 eyes had VAO. Other complications requiring secondary 
surgery included resuturing in two eyes, conjunctival discomfort related to the sutures 
in two eyes, and anterior synechiae in one eye. Six eyes had no reported complications. 
None of the patients had any serious complication, such as retinal detachment, 
endophthalmitis, or glaucoma during the follow-up. 
 The high incidence of VAO in this paper was expected. The lens 
epithelial cells in children are very lively, and it has been reported that VAO could be 
highly expected in pediatric eyes operated for cataract, when the surgery is performed 
without posterior capsulorrhexis (Kugelberg &  Zetterstrom 2002). However, posterior 
capsulorrhexis is difficult to perform in cases of EL, and could risk the stability of the 
capsular bag. In this paper we found VAO in 84% of the eyes, and a higher number 
could be expected with a longer follow-up time.  
 Re-suturing was needed in two cases. The stability of the 10-0 Prolene 
suture, also used in this paper, has sometimes been questioned. Late IOL dislocations 
(after 7-14 years) have been reported, and microscopic analysis of the sutures has 
shown degradation and cracking of the suture material (Price et al. 2005). As few 
studies on surgery for EL have such a long follow-up time, this complication is rarely 
reported. Also the cases in this paper could be expected to show a higher number of 
IOL dislocation with a longer follow-up. Still, both VAO and the suture-related 
complications are surgically treatable, and give no permanently sight-threatening 
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consequences. No endophthalmitis, secondary glaucoma or retinal detachment, which 
have been associated with surgery for EL, was seen in these eyes.  
 In conclusion, these results show that surgery for congenital EL in 
children, including a scleral-sutured CTR and primary IOL implantation gives good 
visual development, and has no serious complications.  
  
 
5.2 PAPER II 
5.2.1 Baseline data 
Thirty-one eyes of 31 individuals with Marfan syndrome were included and 31 eyes of 
31 unaffected individuals served as the control group. These two groups had a mean 
age 35.4 years (range, 12.7 - 63.8 years) vs. 34.1 years (11.9 - 61.6 years) (P=0.74), and 
spherical refraction, -3.3 D (-17.5 to +1.5 D) vs. -2.3 D (-10.3 to +2.5 D) (P=0.30).  
 
5.2.2 The lens and anterior chamber depth 
The accommodative power was defined as the change in the refractive power (spherical 
equivalent) from baseline to maximal accommodation. In the MFS eyes, the spherical 
power changed from -3.5 ± 4.0 D (mean± standard deviation) at baseline to -10.1 ± 5.0 
D in full accommodation, adding to an accommodative power of -6.6 ± 2.2 D. In the 
control eyes the same results were -2.6 ± 3.2 D, -9.4 ± 4.0 D, and -6.8 ± 2.3 D. None of 
these differences were statistically significant. Further, no statistically significant 
difference was found in anterior chamber depth (ACD) at the different stages (P=0.17-
0.21). In the eyes with MFS, the lens was significantly thicker at baseline, 
accommodation and dilatation (Table 2). 
 
 
Table 2. The lens thickness in MFS eyes and controls at baseline, in accommodation and in 
dilatation, expressed as mean ± standard deviation.  
95% CI= 95% confidence interval of the difference. 
* indicates a statistically significant difference. 
 
Even though EL is a well-known feature of MFS, little is known about the 
accommodation in MFS. To the best of our knowledge, this is the first report on 
accommodation studied with OCT in MFS. A previous study on accommodation in a 
normal population showed the same forward movement of the anterior lens surface, and 
the pupil contraction, as we did in this paper (Baikoff et al. 2004). Histopathologic 
studies have shown both qualitative and quantitative abnormalities in the fibrillin-
  25 
containing structures on the lens surface in MFS eyes (Mir et al. 1998; Traboulsi et al. 
2000). A study with ultrasound biomicroscopy has also shown increased lenticular 
sphericity in areas of zonular abnormalities (Pavlin et al. 1998). In this paper we show 
significant differences in the lens thickness in MFS compared to controls. This might 
be explained by decreased tension in the zonular fibers, leading to a more spherical 
form of the lens in MFS. The increased lens thickness might therefore indicate a 
partially accommodated state in MFS eyes at baseline, adding lenticular myopia to the 
axial myopia in MFS.  
Schachars theory on accommodation has been previously discussed in this 
thesis (chapter 1.2). According to this theory, the lens equator becomes flattened and 
the anterior and posterior lens surfaces steepen during accommodation (Schachar et al. 
1996; Schachar 2004; Schachar 2006). This mechanism might even apply for MFS 
eyes, if the zonules are equally abnormal anterior and posterior of the equator, such as 
previous histopathologic studies have implied (Mir et al. 1998; Traboulsi et al. 2000). 
This is, nevertheless, difficult to confirm with OCT, since the light waves to the lens 
equator are blocked by iris, and does not allow imaging of the outmost part of the lens.  
 
5.2.3 The pupil 
The pupil size in the eyes with MFS at baseline was significantly smaller. In the eyes 
with MFS, the pupil size decreased less during accommodation and increased more 
during dilatation compared to controls (Table 3).  
 
 
 Table 3. The pupil diameter in MFS eyes and controls at baseline, accommodation and in 
dilatation, as well as the different between the different stages, expressed as mean ± standard 
deviation.  
CI 95% = 95% confidence interval of the difference. 
* indicates a statistically significant difference. 
 
The diagnostic criteria for MFS at the time of this paper (De Paepe et al. 1996) 
included iris hypoplasia, causing decreased miosis, as a minor ocular criteria for MFS. 
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Although our results show less change in the pupil size in MFS eyes, the decreased 
ability for miosis is difficult to confirm only referring to this difference, since the pupils 
were significantly smaller in MFS eyes at the baseline. This difference at the baseline 
might also contribute to the increased difference in pupil size from baseline to 
accommodation, even though it does not seem to explain the whole difference. The iris 
in MFS could also be more susceptible to pharmacological agents than normal eyes.  
Interestingly, we found no significant difference in the accommodative power, 
ACD, lens thickness or pupil size, between MFS eyes with and without EL. This might 
implicate that there are subclinical changes in the zonules and iris even before EL 
becomes visible in a slit lamp examination, and is probably explained by the 
progressive nature of the connective tissue abnormalities previously shown in MFS. 
Nevertheless, measured with OCT, there is no difference in the ability of the MFS eyes 
to accommodate compared to control eyes, which is an indication that the remaining 
zonules in MFS seem to function in a similar manner than in normal eyes.  
 
 
5.3 PAPER III 
5.3.1 Baseline data 
Thirty-nine eyes of 39 individuals with MFS were included. Forty eyes of 40 
unaffected individuals served as the control group. The mean age in these groups were 
35.9 ± 15.5 years (mean ± standard deviation (SD)) vs. 36.6 ± 14.5 years (P=0.83). The 
mean spherical refraction was -1.75 D (-17.5 to +1.5 D) vs. -1.25 D (-10.3 to +2.5 D) 
(P=0.18).  
 
5.3.2 Corneal assessments  
The mean keratometric value (Kmed value) in the MFS eyes was significantly lower 
than in the control eyes (Table 4). Also, 15 MFS eyes (38%) had a Kmed value below 
41.5 D compared to three (8%) controls, which was significantly different (P=0.0012). 
However, we found no significant difference in the mean Kmed value between the MFS 
eyes with and without lens subluxation (P=0.87) (Table 5).  
 
 
Table 4. The Kmed , corneal astigmatism and corneal thickness in MFS eyes compared to 
controls, expressed as the mean ± standard deviation. 
95% CI= 95% confidence interval of the difference. 
* indicates a statistically significant difference. 
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Table 5. The Kmed , corneal astigmatism and corneal thickness in MFS eyes with and without 
ectopia lentis (EL), expressed as the mean ± standard deviation. 
95% CI= 95% confidence interval of the difference. 
* indicates a statistically significant difference. 
  
Abnormally flat cornea was included in the clinical diagnostic criteria for MFS at the 
time of this paper, even though the threshold value was never well defined. Several 
previous studies have confirmed this well-known feature, and K values below 41.5 D 
are commonly seen (Maumenee 1981; Sultan et al. 2002; Heur et al. 2008). This was 
the case also in this paper. Despite the fact that the corneal curvature no longer is 
included in the diagnostic criteria for MFS (Loeys et al. 2010), other signs of MFS 
should be looked for in eyes with very low K values. 
 MFS eyes had more corneal astigmatism compared to control eyes 
(P=0.035) (Table 4). Further, nine MFS eyes (23%) but only two control eyes (5%) had 
corneal astigmatism exceeding 1.5 D (P=0.025). Interestingly, the same nine MFS eyes 
also had a subluxated lens. In general, MFS eyes with a subluxated lens had 
significantly more corneal astigmatism than those without a subluxated lens (P=0.0002) 
(Table 5). The possible connection between corneal astigmatism and EL is unclear. It 
has been suggested that oblique viewing could cause false measurements of corneal 
astigmatism, and that an ectopic lens could be comparable to oblique viewing. 
However, a previous study on refractive changes measured due to oblique viewing, 
showed insignificant changes on the total refraction, as well as astigmatism or higher 
grade of aberrations (Radhakrishnan &  Charman 2007). We therefore hypothesized 
that the eyes with EL also have structural defects in the cornea, causing corneal 
astigmatism.  
Keratoconus has sometimes been connected to MFS, but to the best of 
our knowledge, this has never been reported in a clinical study. In this paper, all the 
Orbscan images were analyzed carefully, and no MFS or control eyes had keratoconus, 
despite of high corneal astigmatism. 
The mean corneal thickness at the thinnest point was significantly 
decreased in MFS eyes compared to control eyes (Table 4). The number of MFS eyes 
with very thin corneas (with corneal thickness below 500 µm) was significantly higher 
than in the control eyes, 24 MFS eyes (62%) vs. 10 control eyes (25%) (P=0.01). 
However, the difference in the mean corneal thickness between the MFS eyes with and 
without a subluxated lens was not statistically significant (Table 5). Thirteen MFS eyes 
with a subluxated lens (72%) and 11 MFS eyes without a subluxated lens (52%) had 
corneal thickness below 500 µm at the thinnest point (P=0.32). All eyes with thin 
corneas in this paper had generally thin corneas, and no local thinning, as is the case in 
keratoconus. Some previous studies on corneal changes in MFS did not show corneal 
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thinning (Maumenee 1981; Setala et al. 1988), whereas the more recent ones report the 
same corneal thinning as we did (Sultan et al. 2002; Heur et al. 2008). This could be 
due to more accurate instruments used today.  
No significant difference in ECD was found between the MFS eyes and 
control eyes (P=0.66). In addition, there was no significant difference in the ECD 
between MFS eyes with and without a subluxated lens (P=0.22). This is equal to a 
previous report by Setala et al. (Setala et al. 1988). Even though MFS does not seem to 
affect the ECD, alterations in the endothelial morphology have been reported in MFS 
eyes (Setala et al. 1988; Iordanidou et al. 2007). 
 We found no statistically significant difference in Kmed or in corneal 
thickness between MFS eyes with and without EL. This indicates that these changes are 
typical of MFS in general, and not specifically associated to EL.  
 
 
5.4 PAPER IV 
5.4.1 Ocular characteristics  
One hundred and two eyes of 51 individuals were included (23 males, 28 females). The 
mean age among the participants was 39.0 years (range, 12.7-71.6 years). 
Thirty-one eyes (30%) of 16 participants had EL, and 12 eyes (12%) of 
eight participants had signs of cataract at the time of the study. Nine eyes (9%) of nine 
participants had a history of strabismus, two of whom underwent surgery in one eye. 
Three eyes (3%) of three participants had amblyopia, all of whom had EL and two of 
who also had strabismus. Four eyes (4%) of three participants underwent surgery for a 
retinal detachment (RD); two of these eyes were blind and had a history of both a 
surgically dislocated lens and RD. Five eyes (5%) of three participants received 
medical treatment for glaucoma. One eye (1%) had optic nerve atrophy of unclear 
genesis, with a VA of counting fingers. Twenty-two eyes (22%) of 12 participants did 
not have any ocular complications. Two eyes were amaurotic and were not studied 
further. 
 
5.4.2 Phakic eyes 
Seventy-seven eyes were phakic. The mean age among these participants was 36.2 
years (range, 12.7-71.6 years). The mean BSCVA in the phakic eyes was -0.024 
logMAR (range, 0.5 to -0.2 logMAR).  
The phakic eyes had a mean spherical refraction of -2.78 D (range, -17.50 
to +2.00 D) (Figure 8), -1.36 D of cylinder (range, -5.5 to ± 0 D), and a spherical 
equivalent of -3.46 D (range, -17.75 to +1.75 D). Four eyes were excluded from 
computation of this mean value: two eyes in which the subjective refraction could not 
be determined because of BSCVA less than 1 logMAR, and two eyes which had a 
spherical refraction +0.5 and +0.75 D due to previous corneal refractive surgery.  
The mean AL among the phakic eyes was 24.73 mm (range, 21.59 - 
32.75), including 39 eyes (51%) with an elongated AL (≥ 24.5 mm) (Figure 9). The 
mean Kmed was 42.2 D (range, 38.7 - 46.9 D). Two eyes were excluded from the 
computation of the Kmed due to previous corneal refractive surgery.  
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Figure 8. The distribution of the spherical refraction in diopters (D) in phakic eyes with 
Marfan syndrome. 
 
 
Figure 9. The distribution of the axial length in mm in phakic Marfan eyes. 
 
Of the 77 phakic eyes, 31 eyes (40%) had EL. Twenty-seven of those eyes were 
myopic (87%). Twelve eyes with EL (39%) had myopia exceeding -3 D. Of the 46 
phakic eyes without EL, 33 eyes were myopic (71%). Twelve eyes (26%) had myopia 
exceeding -3 D.  
In eyes with and without EL, no statistically significant difference was 
seen in the mean spherical refraction (P=0.44), spherical equivalent (P=0.07), AL 
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(P=0.76), Kmax (P=0.67), Kmin (P=0.11), or Kmed (P=0.56). An abnormally high AL (≥ 
24.5 mm) was seen in 39 of all the 77 phakic eyes (51%); in 17 eyes (55%) with EL, 
and in 22 eyes (48%) without EL.  
However, fifteen eyes (48%) with EL had lens-related astigmatism, 
defined as a difference by at least 1.0 D in subjective astigmatism compared to corneal 
astigmatism. In comparison, only four eyes (12%) without visible EL had lens-related 
astigmatism. Two of those four eyes had ectopia pupillae. 
These results confirm the well-known fact that increased axial length is a 
common feature in MFS. However, only a minor part (36%) of the eyes show high 
myopia, which would be expected in eyes with high axial length. This could be 
explained by the flat cornea, which seems to compensate for the total subjective 
refraction. Further, only 26% of the phakic eyes without EL showed myopia exceeding 
3.0 D. This means that only about one fourth of the MFS eyes without EL fill the 
current ocular diagnostic criteria for MFS. This increases the risk of misdiagnosing 
patients with MFS in suspected cases. Therefore, we suggest that also corneal curvature 
and AL should be measured and evaluated in the cases of suspected MFS without 
visible signs of EL.  
 
5.4.3 Aphakic eyes 
Five eyes were aphakic. The mean age among the participants with aphakic eyes was 
57.3 years (range, 50.9 - 63.2 years). Four of these lenses were surgically dislocated 
into the vitreous during the 1950’s when two of the patients were children. Two of 
these lenses were later extracted, one due to vitreitis and the other one due to RD. In 
one of the five aphakic eyes, the lens was primarily extracted during the 1970’s. Three 
of these eyes had a BSCVA of 0.1 logMAR, and two were amaurotic. Both of the 
amaurotic eyes had had surgical dislocation of the lenses, and one of the lenses was 
later extracted. Both eyes also had a history of a RD. 
 
5.4.4 Pseudophakic eyes 
Twenty eyes were pseudophakic. The mean age among the pseudophakic participants 
was 48.0 years (range, 17.0 - 71.6 years). Seventeen of those underwent surgery 
primarily because of EL, two eyes because of a combination of EL and cataract, and 
one eye because of cataract. Twelve eyes had a sutured posterior chamber intraocular 
lens (IOL). Six eyes had an IOL implanted in the capsular bag. Two eyes had an 
anterior chamber IOL. One eye had undergone surgery for a RD years after the lens 
surgery. The pseudophakic eyes had in general good visual acuity: the mean BSCVA 
was 0.15 logMAR (range, 0.8 to -0.1 logMAR).  
 Our results showed current EL or history of EL in 55 of 102 eyes (54%). 
The frequency of EL in previous reports varies from 60% (Maumenee 1981) to 89% 
(Sultan et al. 2002). The ectopic lens causes a great deal of lenticular astigmatism, 
which could be explained by either tilting of the lens or displacement of the center of 
the lens from the optical axis. Also, as we have shown in paper II, the lens is thicker in 
MFS compared to controls in a non-accommodated state, which could indicate a partly 
accommodated state at baseline. This is probably explained by decreased zonular 
tension, which could further contribute to myopia.  
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 The mean age in the pseudophakic eyes in this paper was 48 years. This 
could be compared to a mean age of 75 years in patients who had cataract surgery in a 
normal population (Behndig et al. 2011). Most of the participants in this paper had had 
lens surgery mainly due to EL, but cataract is over-represented in eyes with EL, and 
could be expected at a younger age than in normal population. 
 The age difference between the subgroups (phakic, pseudophakic and 
aphakic) eyes is partly an indication of the progressive nature of EL. The younger 
participants were still phakic, though many showed signs of EL. At the same time, it is 
an indicator of the evolution in the surgical techniques in managing EL. The aphakic 
participants were middle-aged and had had their lenses surgically extracted or 
dislocated during childhood, but no IOL was implanted in the primary surgery. This 
had led to a poor visual development in some cases. On the other hand, the participants 
that had had surgery in the recent years had all received an IOL.  
 The risk of retinal detachment (RD) has previously kept the ocular 
surgeons away from the eyes with EL as long as possible. The incidence of RD 
reported in this paper was 4%. This could be compared to an incidence of 10% reported 
previously (Maumenee 1981). The risk of RD in MFS could be due to increased AL, 
previous intraocular surgery, EL causing vitreous traction, or a combination of these 
factors. However, it seems that RD in MFS eyes is managed better today, 
independently of whether the eyes is phakic or aphakic (Loewenstein et al. 2000). All 
pseudophakic eyes in this paper underwent surgery before 2000, and only one of them 
had a history of RD postoperatively. This could indicate that the techniques of lens 
surgery have improved, and that the risk of RD is therefore not significantly increased 
in eyes operated for EL.  
 In the updated diagnostic criteria for MFS, EL is included as one of the 
main criteria for MFS. When EL is not present, a myopia exceeding 3.0 D is used as a 
diagnostic factor. Our results show that only a minor part of the MFS eyes without EL 
have a total refraction exceeding this value, and it seems that both increased bulb length 
and flattened cornea affect the subjective refraction, though in opposite directions. We 
suggest that these factors should be taken into account when examining cases with 
suspected MFS.  
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6 MAIN CONCLUSIONS 
1. Surgery for congenital ectopia lentis in children, which includes scleral-fixated 
capsular tension ring and primary implantation of an intraocular lens in the bag, 
gives good visual outcomes, and has no serious complications. 
 
2. Even though the pupil and crystalline lens are affected in MFS, these lenses 
seem to accommodate normally. The observed changes in the pupil and lens 
seem to be connected to MFS itself rather than ectopia lentis.  
 
3. Cornea in MFS is flattened and thinned. High corneal astigmatism is over-
represented in MFS, especially in eyes with ectopia lentis. Keratoconus does 
not seem to be associated to MFS.  
 
4. In addition to ectopia lentis, increased axial length and flattened cornea are 
typical ocular characteristics in MFS. The flattened cornea may compensate for 
high myopia, which would otherwise be expected in eyes with ectopic lens and 
increased axial length.  
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7 FUTURE PERSPECTIVES 
Still today many children with EL are managed conservatively, due to fear of surgical 
complication. Or, when surgery is performed, lensectomy is performed, with aphakia as 
a result. As we show in paper I, a scleral-fixated CTR and an IOL implanted in the bag 
gives good visual rehabilitation in children. This method could be used more widely for 
correction for EL, allowing more children to get early surgery, and decreasing the risk 
of amblyopia. In the cohort studied in paper I, the follow-up was not especially long in 
some cases. Also, many of the patients still were very young, and their visual acuity 
was not yet fully developed. Therefore, the long-term visual development would be 
interesting to follow up, as well as the possible long-term complications.   
 The demonstration of the connection between the TGF-β signalling 
pathway and MFS has changed the view on MFS from a structural disease towards a 
functional one. This opens for new therapeutic strategies, which could have life-saving 
effects on MFS patients. The ongoing treatment studies with losartan on humans seem 
therefore very interesting, and the future will show, whether this medication, or other 
treatments for modifying the TGF-β signalling pathway, could have an effect on some 
of the systemic features in MFS. Could it possibly decrease the risk of aortic root 
dilatation and dissection, and in the ophthalmological spectrum, stop the development 
of lens ectopia? 
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8 SAMMANFATTNING PÅ SVENSKA 
 
Delarbete I 
 
Två av de viktigaste delarna i ögats optiska system är hornhinnan och linsen som 
samlar inkommande ljusstrålar så att en klar bild skapas på näthinnan. En viktig 
förutsättning för att en klar bild skapas är att linsen ligger på sin naturliga plats, strax 
bakom pupillöppningen. Om linsen är snedställd i förhållande till pupillöppningen, 
påverkas synen negativt. Snedställdhet av linsen orsakar i första hand kraftig närsynthet 
och astigmatism. Det kan också störa cirkulationen av kammarvätskan inuti ögat och 
därmed orsaka förhöjt ögontryck med synnervsskada (glaukom). Vidare ger 
snedställdhet ökad risk för näthinneavlossning. Alla dessa komplikationer är potentiellt 
synhotande, framför allt hos barn som kan få bestående svagsynthet om inte 
snedställdhet och dess komplikationer upptäcks och åtgärdas effektivt i tid. Den 
medicinska term som används för snedställdhet av ögats lins är ectopia lentis. 
Behandling av snedställda linser har varit omdiskuterat. Kirurgi av snedställda 
linser har ansetts svårt eftersom linsen sitter mer eller mindre lös. Därför har kirurgi 
ofta förknippats med allvarliga komplikationer. Samtidigt har flera studier visat att 
enbart glasögonkorrektion inte ger bra synutveckling hos barn med snedställda linser. 
De senaste årtiondena har operationsmetoderna förbättrats och komplikationsrisken 
minskat, framför allt efter introduktion av implantat (s.k. kapselringar) som stabiliserar 
linssäcken vid ögonkirurgi. Dessa kapselringar läggs in i linssäcken efter att linsens 
innehåll tömts, varefter en konstgjord lins kan läggas in. De första kapselringarna kom i 
början av 1990-talet när man introducerade den första typen av kapselring som läggs in 
i linskapseln för att spänna ut den. Denna typ av kapselring kan användas vid lättare 
snedställdhet. En nyare typ av kapselring kan sys fast genom ögats vägg för att 
stabilisera linssäcken vid mera uttalad snedställdhet.  
I delarbete I studerades synutveckling och komplikationer hos barn som opererats 
för snedställd lins med en fastsydd kapselring och insättning av en konstgjord lins. 
Studien omfattade 37 ögon hos 22 barn och visade att alla barn fick bättre synskärpa 
efter operationen. Den vanligaste komplikationen efter operationen var efterstarr som 
påvisades i 31 ögon. Av dessa hade 26 blivit behandlade för efterstarr vid studiens slut. 
Efterstarr efter linskirurgi är förväntat hos barn eftersom linscellerna är mycket livliga 
hos dem. Inget barn hade dock några allvarliga komplikationer under eller efter den 
första operationen. Dessa resultat tyder på att denna operationsmetod är trygg för barn 
och ger bra synutveckling utan svåra komplikationer.  
 
 
Delarbete II-IV 
 
Medfödd snedställdhet av ögats lins är oftast en del av en ärftlig bindvävssjukdom. 
Marfans syndrom (MFS) är den vanligaste av dessa. Cirka 70 % av alla med snedställd 
lins har också MFS. Omkring en av 5000 människor drabbas av MFS statistiskt sett och 
syndromet är lika vanligt hos män som hos kvinnor bland alla etniska grupper i världen. 
De huvudsakliga diagnostiska kriterierna är snedställdhet i ögats lins, vidgning av 
kroppspulsådern och typiska genetiska förändringar. Typiska synliga förändringar vid 
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MFS är lång och smal kroppsbyggnad med långa (spindellika) fingrar och tår, 
felställningar i ryggraden eller bröstkorgen och överrörliga leder. Trots att de genetiska 
diagnostiska metoderna förbättrats genom åren baseras MFS-diagnosen fortfarande 
mycket på symptomen och fynden i olika organ. 
Bindväv finns i många delar av ögat och MFS kan därför drabba ögat på flera olika 
sätt. Man har i tidigare studier bl.a. konstaterat att hornhinnan är plattare och att ögat är 
längre än normalt. Linsen är upphängd med tunna elastiska bindvävstrådar, s.k. 
zonulatrådar, som fäster i en omgivande ringmuskel. Zonulatrådarna fungerar som 
fjädrarna i en studsmatta och ger linsen dess spänst. När ögat fokuserar på nära håll 
(ackommoderar) drar ringmuskeln ihop sig, trådarna slappnar av och linsen får en 
rundare form. Därmed förstärks linsens ljusbrytande styrka. När ögat sedan fokuserar 
på långt håll slappnar ringmuskeln av, zonulatrådarna spänns ut och linsen plattas till. 
Vid MFS är zonulatrådarna försvagade eller brutna vilket leder till snedställdhet av 
linsen.  
I delarbete II studerades hur ackommodation fungerar i ögon med snedställda 
linser. Studien omfattade 31 ögon hos 31 personer med MFS samt 31 ögon hos 31 
friska individer (kontroller). Graden av ackommodation och förändringar i ögats främre 
delar studerades vid full ackommodation och efter att pupillvidgande ämnen droppats. 
Vi kunde konstatera att MFS ögon hade lika bra ackommodationsförmåga som friska 
kontroller samt att linsen vid MFS är tjockare än hos kontrollerna. Man ser alltså 
påverkan på linsen vid MFS men trots det verkar dessa linser ha bra 
ackommodationsförmåga. Vi kunde inte påvisa någon skillnad mellan MFS ögon med 
och utan snedställd lins vilket talar för att dessa förändringar är typiska för MFS och är 
inte beroende av endast att linsen är lös. Det kan därför antas att även MFS ögon utan 
påvisad snedställd lins har begynnande svagheter i sina zonulatrådar trots att detta inte 
kunnat ses vid vanlig ögonundersökning.  
I delarbete III studerades hornhinnan vid MFS. I studien ingick 39 ögon hos 39 
personer med MFS och 40 ögon hos 40 friska kontroller. Vi mätte bl.a. hornhinnans 
kurvatur och tjocklek och kunde se att hornhinnan är inte bara plattare men också 
tunnare i MFS ögon än hos kontroller. Det förelåg ingen skillnad mellan MFS ögon 
med och utan sned lins vilket talar för att också dessa förändringar är typiska för själva 
MFS, oberoende av snedställd lins. Detta tyder på att avvikande tjocklek och platthet i 
hornhinnan skulle kunna användas som stöd i diagnostiken av MFS. 
I delarbete IV beskriver vi ögonförändringarna hos 56 personer med MFS. De 
flesta av dessa hade snedställd lins vid undersökning eller hade blivit tidigare opererade 
för det. Andra ögonförändringar vi noterade var glaukom, skelning, 
näthinneavlossning, synsvaghet och blindhet. Vi kunde också se att ögat var ovanligt 
långt hos många, vilket hade medfört närsynthet, dock inte i den grad som man skulle 
kunna förvänta sig. Hornhinnans platthet tycktes kompensera för det i många fall. I de 
uppdaterade diagnostiska kriterierna för MFS är hög närsynthet ett diagnostiskt 
kriterium hos dem som inte har snedställd lins. Eftersom många personer med MFS 
endast visar lätt närsynthet finns också en risk att dessa personer inte blir 
diagnostiserade för MFS om man vid diagnostiken inte samtidigt tar hänsyn till de 
andra typiska ögonförändringarna, dvs. platt och tunn hornhinna samt onormalt långt 
öga.  
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